Ocugen Announces Agreement With Washington University in St. Louis for Commercialization of Intranasal COVID-19 Vaccine in U.S., Europe, and Japan
Stock Information for Ocugen, Inc.
Loading
Please wait while we load your information from QuoteMedia.